Song Qin Selected Research

Phycocyanin

12/2020	Effects of phycocyanin on pulmonary and gut microbiota in a radiation-induced pulmonary fibrosis model.
10/2019	The effects of phycocyanin on bleomycin-induced pulmonary fibrosis and the intestinal microbiota in C57BL/6 mice.
1/2017	Phycocyanin attenuates pulmonary fibrosis via the TLR2-MyD88-NF-κB signaling pathway.
9/2012	[Experimental study on the therapeutic effect of C-phycocyanin against pulmonary fibrosis induced by paraquat in rats].
9/2011	The protective effect of C-phycocyanin on paraquat-induced acute lung injury in rats.
9/2006	Antioxidant properties of recombinant allophycocyanin expressed in Escherichia coli.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Song Qin Research Topics

Disease

11	Neoplasms (Cancer) 12/2020 - 03/2005
7	Inflammation (Inflammations) 01/2022 - 01/2019
6	Acute Lung Injury 01/2021 - 09/2011
5	Infections 01/2021 - 03/2010
4	Wounds and Injuries (Trauma) 01/2022 - 03/2020
4	Lung Injury 01/2021 - 01/2016
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2020 - 09/2012
4	Breast Neoplasms (Breast Cancer) 09/2020 - 03/2011
4	Alzheimer Disease (Alzheimer's Disease) 03/2004 - 09/2002
2	Diarrhea 08/2022 - 01/2020
2	Pain (Aches) 12/2021 - 04/2020
2	Sepsis (Septicemia) 01/2021 - 01/2018
2	Pneumonia (Pneumonitis) 12/2020 - 03/2016
2	Obesity 12/2020 - 01/2020
2	Dehydration (Water Stress) 01/2020 - 04/2005
2	Body Weight (Weight, Body) 01/2020 - 07/2013
2	Hyperoxia 01/2019 - 09/2013
2	Adenocarcinoma of Lung 03/2012 - 01/2011
2	Hepatocellular Carcinoma (Hepatoma) 03/2012 - 06/2005
2	Myocardial Infarction 12/2008 - 07/2005
2	Cognitive Dysfunction 04/2007 - 09/2002
1	Hemorrhage 01/2022
1	Starvation 12/2021
1	Flushing 11/2021
1	Pulmonary Edema 01/2021
1	Radiation Pneumonitis 12/2020
1	Neuroinflammatory Diseases 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Depressive Disorder (Melancholia) 12/2020
1	Memory Disorders (Memory Loss) 12/2020
1	Amyloid Plaque 11/2020
1	Hemolysis 09/2020
1	Open Fractures (Compound Fracture) 04/2020
1	Soft Tissue Injuries (Soft Tissue Injury) 04/2020
1	Burns 03/2020
1	Dysbiosis 01/2020
1	Nausea 01/2020
1	Endotoxemia 01/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2020 - 07/2005
6	PhycocyaninIBA 12/2020 - 09/2006
4	CollagenIBA 01/2022 - 03/2020
3	LipopolysaccharidesIBA 01/2022 - 10/2019
3	AlginatesIBA 01/2022 - 04/2020
3	Biological ProductsIBA 07/2021 - 12/2020
3	CytokinesIBA 01/2021 - 02/2018
3	Messenger RNA (mRNA)IBA 01/2011 - 03/2010
2	OligosaccharidesIBA 01/2022 - 04/2020
2	Hemostatics (Antihemorrhagics)IBA 01/2022 - 07/2021
2	Biocompatible Materials (Biomaterials)IBA 07/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2019
2	EnzymesIBA 01/2021 - 08/2016
2	Dietary Fiber FDA Link 12/2020 - 01/2020
2	HydrogelsIBA 09/2020 - 03/2020
2	Pharmaceutical PreparationsIBA 09/2020 - 01/2011
2	EndotoxinsIBA 01/2020 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2016
2	CalreticulinIBA 02/2018 - 10/2017
2	AntigensIBA 02/2018 - 10/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 02/2018 - 10/2017
2	MicroRNAs (MicroRNA)IBA 09/2013 - 10/2008
2	ParaquatIBA 09/2012 - 09/2011
2	anthraceneIBA 07/2012 - 01/2011
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2008 - 07/2005
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2008 - 07/2005
2	allophycocyaninIBA 09/2006 - 06/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	NitrogenIBA 12/2021
1	Chlorophyll AIBA 12/2021
1	WastewaterIBA 11/2021
1	Aquaporins (Water Channels)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	PrionsIBA 01/2021
1	MEF2 Transcription FactorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	InflammasomesIBA 12/2020
1	Volatile Fatty AcidsIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	tdTomatoIBA 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2020
1	N 30IBA 04/2020
1	Cefazolin (Ancef)FDA LinkGeneric 04/2020
1	PrebioticsIBA 01/2020
1	LeptinIBA 01/2020
1	Inulin FDA Link 01/2020
1	Leptin ReceptorsIBA 01/2020
1	NestinIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2019
1	Hematoxylin (Haematoxylon)IBA 10/2019
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2019
1	Carisoprodol (Soma)FDA LinkGeneric 06/2019

Therapy/Procedure

2	Radiotherapy 12/2020 - 12/2019
2	Aftercare (After-Treatment) 04/2020 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Length of Stay 12/2021
1	Punctures 01/2021
1	Ligation 01/2021